Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community
- PMID: 15753907
- DOI: 10.1016/j.jaci.2004.12.1122
Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community
Abstract
Anaphylaxis often occurs in the community in the absence of a health care professional. Prompt administration of self-injectable epinephrine as first-aid treatment in the context of a personalized emergency action plan is the key to survival. There is little argument that physicians should prescribe self-injectable epinephrine for individuals who have already experienced anaphylaxis involving respiratory distress or shock triggered by allergens that might be encountered in the community. A quandary faced by physicians is that additional individuals with identified allergy who have no recognized prior history of anaphylaxis or who have a history of mild symptoms after exposure to a known trigger might also be at risk for subsequent life-threatening anaphylaxis and might also warrant prescription of self-injectable epinephrine. Prescribing for the latter individuals requires considerable clinical judgment and has led to controversy regarding possible overprescription or underprescription of self-injectable epinephrine. A second quandary for physicians occurs with regard to the advice they should give to at-risk individuals about actual use of their self-injectable epinephrine. It is difficult for health care professionals, let alone persons with no health care training, to predict whether anaphylaxis symptoms will occur in an at-risk individual after exposure to a known trigger. Moreover, at the onset of an acute allergic reaction, it is difficult to predict the symptoms that will ultimately develop. We examine these 2 common quandaries and provide examples of clinical scenarios and potential pitfalls in the management of persons identified as being at risk for anaphylaxis in the community. Additional studies of the recognition and treatment of anaphylaxis in the community are needed to develop comprehensive, evidence-based recommendations for its management in this setting.
Comment in
-
Pathogenesis and management of anaphylaxis: current status and future challenges.J Allergy Clin Immunol. 2005 Mar;115(3):571-4. doi: 10.1016/j.jaci.2004.12.1133. J Allergy Clin Immunol. 2005. PMID: 15753906 No abstract available.
Similar articles
-
Self-injectable epinephrine for first-aid management of anaphylaxis.Pediatrics. 2007 Mar;119(3):638-46. doi: 10.1542/peds.2006-3689. Pediatrics. 2007. PMID: 17332221 Review.
-
Anaphylaxis, killer allergy: long-term management in the community.J Allergy Clin Immunol. 2006 Feb;117(2):367-77. doi: 10.1016/j.jaci.2005.12.002. J Allergy Clin Immunol. 2006. PMID: 16461138 Review.
-
First-aid treatment of anaphylaxis to food: focus on epinephrine.J Allergy Clin Immunol. 2004 May;113(5):837-44. doi: 10.1016/j.jaci.2004.01.769. J Allergy Clin Immunol. 2004. PMID: 15131564 Review.
-
Self-injectable epinephrine for allergic emergencies.J Emerg Med. 2009 Jul;37(1):57-62. doi: 10.1016/j.jemermed.2007.06.038. Epub 2008 Feb 1. J Emerg Med. 2009. PMID: 18242927 Review.
-
Epinephrine for First-aid Management of Anaphylaxis.Pediatrics. 2017 Mar;139(3):e20164006. doi: 10.1542/peds.2016-4006. Epub 2017 Feb 13. Pediatrics. 2017. PMID: 28193791 Review.
Cited by
-
10 practical priorities to prevent and manage serious allergic reactions: GA2LEN ANACare and EFA Anaphylaxis Manifesto.Clin Transl Allergy. 2024 Dec;14(12):e70009. doi: 10.1002/clt2.70009. Clin Transl Allergy. 2024. PMID: 39614094 Free PMC article. Review.
-
Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock.Cochrane Database Syst Rev. 2008 Oct 8;2008(4):CD006312. doi: 10.1002/14651858.CD006312.pub2. Cochrane Database Syst Rev. 2008. PMID: 18843712 Free PMC article.
-
Demonstration of epinephrine autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement.Allergy Asthma Clin Immunol. 2014 Sep 19;10(1):49. doi: 10.1186/1710-1492-10-49. eCollection 2014. Allergy Asthma Clin Immunol. 2014. PMID: 25264449 Free PMC article.
-
Clinical immunology review series: an approach to the patient with anaphylaxis.Clin Exp Immunol. 2008 Jul;153(1):1-9. doi: 10.1111/j.1365-2249.2008.03694.x. Clin Exp Immunol. 2008. PMID: 18577027 Free PMC article. Review.
-
Pilot Project of Special Emergency Medical Service Team for Anaphylaxis in Gangwon-do, Korea: Results from an Online Questionnaire Survey.J Korean Med Sci. 2021 Nov 1;36(42):e258. doi: 10.3346/jkms.2021.36.e258. J Korean Med Sci. 2021. PMID: 34725975 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical